Perspective Therapeutics, Inc. Common Stock

CATX58

$8.92arrow_drop_down10.12%-$1.00

CATX58

$8.92

arrow_drop_down10.12%-$1.00

Performance History

Key Stats
Open	$10.03
Prev. Close	$9.93
EPS	-1.47
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	8.76	10.15
52 Week Range	2.20	19.10

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.47

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Perspective Therapeutics, Inc. Common Stock (CATX)

Perspective Therapeutics, Inc. Common Stock (CATX) is a publicly traded company in the biotechnology industry. The company focuses on the development and commercialization of innovative therapies for various diseases. CATX stock has a price history that can be tracked over time, allowing investors to assess its performance. By analyzing the stock price history, investors can identify trends and patterns that may indicate future price movements.

CATX stock quotes provide the current market price of Perspective Therapeutics, Inc. Common Stock. This information is essential for investors who want to buy or sell shares of the company. Traders can monitor the stock quotes to make informed decisions about their investments. Additionally, CATX stock news offers updates on the company's latest developments, such as clinical trial results, regulatory approvals, or partnerships. This information can impact the stock price and help investors stay up to date with the latest market trends.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Johan M. Spoor
Headquarters: Richland
Employees: 91
Exchange: NYSE

add Perspective Therapeutics, Inc. Common Stock to watchlist

Keep an eye on Perspective Therapeutics, Inc. Common Stock

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Perspective Therapeutics, Inc. Common Stock's (CATX) price per share?

The current price per share for Perspective Therapeutics, Inc. Common Stock (CATX) is $8.92. The stock has seen a price change of -$1 recently, indicating a -10.12% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Perspective Therapeutics, Inc. Common Stock (CATX)?

For Perspective Therapeutics, Inc. Common Stock (CATX), the 52-week high is $19.1, which is 114.13% from the current price. The 52-week low is $2.2, the current price is 305.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Perspective Therapeutics, Inc. Common Stock (CATX) a growth stock?

Perspective Therapeutics, Inc. Common Stock (CATX) has shown an average price growth of -3.55% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Perspective Therapeutics, Inc. Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Perspective Therapeutics, Inc. Common Stock (CATX) stock price performance year to date (YTD)?

As of the latest data, Perspective Therapeutics, Inc. Common Stock (CATX) has a year-to-date price change of 122.33%. Over the past month, the stock has experienced a price change of -27.42%. Over the last three months, the change has been -33.13%. Over the past six months, the figure is -49.32%.

help

Is Perspective Therapeutics, Inc. Common Stock (CATX) a profitable company?

Perspective Therapeutics, Inc. Common Stock (CATX) has a net income of -$46.51M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -5.05K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$40.94M. Furthermore, the EBITDA is -$54.98M.

help

What is the market capitalization of Perspective Therapeutics, Inc. Common Stock (CATX)?

Perspective Therapeutics, Inc. Common Stock (CATX) has a market capitalization of $601.45M. The average daily trading volume is 9.07, indicating the stock's liquidity and investor engagement.

News

RADIOPHARMACEUTICALS

CANCER TREATMENT

FIBROBLAST ACTIVATION PROTEIN-ALPHA

NEUROENDOCRINE TUMORS

Oct 23, 2024

Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine

Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day

PERSPECTIVE THERAPEUTICS

PRICE TARGETS

STOCK PERFORMANCE

Jul 16, 2024

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet - Zacks Investment Research

COMPANY ANNOUNCEMENT

Jun 12, 2024

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index

COMPANY ANNOUNCEMENT

Jun 10, 2024

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

COMPANY ANNOUNCEMENT

May 24, 2024

Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Perspective Therapeutics, Inc. Common Stock (CATX)

Keep an eye on Perspective Therapeutics, Inc. Common Stock

Frequently Asked Questions

What is Perspective Therapeutics, Inc. Common Stock's (CATX) price per share?

What is the 52-week high and low for Perspective Therapeutics, Inc. Common Stock (CATX)?

Is Perspective Therapeutics, Inc. Common Stock (CATX) a growth stock?

What is Perspective Therapeutics, Inc. Common Stock (CATX) stock price performance year to date (YTD)?

Is Perspective Therapeutics, Inc. Common Stock (CATX) a profitable company?

What is the market capitalization of Perspective Therapeutics, Inc. Common Stock (CATX)?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level